EEIG1 Activators
Early Estrogen-Induced Gene 1 Protein (EEIG1) is a molecular player within the intricate web of cellular signaling, particularly within the context of bone biology and the physiological responses to estrogen. EEIG1 is expressed in various tissues, but it is its role in the regulation of osteoclastogenesis, the process by which osteoclasts - the bone-resorbing cells - are formed, that is of significant interest. The gene encoding EEIG1 is known to be responsive to estrogen signaling, which suggests that its expression is tightly coupled with the hormonal fluctuations that orchestrate a myriad of biological processes, including but not limited to bone density and integrity. The expression of EEIG1 can be upregulated by estrogen, highlighting its potential involvement in the cellular adaptation to hormonal changes, and its function in maintaining the delicate balance between bone formation and resorption - a dance that is essential for skeletal health.
Several chemicals have been identified that could potentially serve as activators of EEIG1 expression, each interacting with complex cellular pathways. Compounds such as 17β-Estradiol, the quintessential form of estrogen, and Diethylstilbestrol, a synthetic estrogen, are thought to have the capacity to stimulate EEIG1 expression through the activation of estrogen receptors, which in turn can initiate a transcriptional cascade resulting in the upregulation of EEIG1. Similarly, environmental estrogens like Bisphenol A may also play a role in the induction of EEIG1, despite the controversy surrounding their effects on the body. On another front, molecules such as Cholecalciferol, or Vitamin D3, may indirectly increase EEIG1 expression by enhancing bone mineralization and homeostasis, processes that are inherently intertwined with osteoclast function and, by extension, potentially EEIG1 activity. Furthermore, phytoestrogens like Genistein, naturally occurring in soy products, and selective estrogen receptor modulators (SERMs) such as Raloxifene and Tamoxifen, can modulate the estrogen pathways, potentially leading to an increase in EEIG1 expression. These chemicals represent a fraction of the diverse array of molecules that, through their interaction with cellular signaling networks, could upregulate EEIG1 and thereby influence its role in the complex biology of bone metabolism.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
This primary form of estrogen could stimulate EEIG1 expression by binding to estrogen receptors, triggering a cascade of gene transcription processes that are likely to include the upregulation of EEIG1 as part of the osteoclast differentiation program. | ||||||
Diethylstilbestrol | 56-53-1 | sc-204720 sc-204720A sc-204720B sc-204720C sc-204720D | 1 g 5 g 25 g 50 g 100 g | $71.00 $287.00 $547.00 $1098.00 $2185.00 | 3 | |
As a synthetic nonsteroidal estrogen, this compound has the potential to increase EEIG1 expression by mimicking the physiological effects of estrogens, thereby initiating transcriptional events that could include the activation of EEIG1 expression. | ||||||
Bisphenol A | 80-05-7 | sc-391751 sc-391751A | 100 mg 10 g | $300.00 $490.00 | 5 | |
Due to its estrogenic activity, Bisphenol A may provoke an upsurge in EEIG1 expression through estrogen receptor-mediated signal transduction pathways that orchestrate gene expression in osteoclasts and other estrogen-responsive cells. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
This synthetic glucocorticoid could elevate EEIG1 expression indirectly by exerting its anti-inflammatory effects, which in turn may alter the homeostasis of bone remodeling, potentially leading to a compensatory upregulation of EEIG1 in osteoclastogenesis. | ||||||
Cholecalciferol | 67-97-0 | sc-205630 sc-205630A sc-205630B | 1 g 5 g 10 g | $71.00 $163.00 $296.00 | 2 | |
Cholecalciferol itself, upon conversion to its active form, could augment EEIG1 expression by promoting calcium absorption and bone homeostasis, which are processes inherently connected to osteoclast activity and potentially the expression of EEIG1. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
This metabolite of vitamin A can stimulate EEIG1 expression through its role in cell differentiation, particularly by enhancing the transcription of genes involved in osteoclast development, which could include EEIG1. | ||||||
Raloxifene | 84449-90-1 | sc-476458 | 1 g | $802.00 | 3 | |
A selective estrogen receptor modulator (SERM) that could upregulate EEIG1 expression through its bone-protective effects, possibly by stimulating signaling pathways that control the balance between bone formation and resorption, including those regulating EEIG1. | ||||||
Simvastatin | 79902-63-9 | sc-200829 sc-200829A sc-200829B sc-200829C | 50 mg 250 mg 1 g 5 g | $31.00 $89.00 $135.00 $443.00 | 13 | |
Although primarily a cholesterol-lowering agent, Simvastatin could stimulate the transcription of EEIG1 by promoting bone-forming activities, which may necessitate the corresponding upregulation of bone resorption genes like EEIG1 to maintain skeletal balance. | ||||||
Ibandronic Acid | 114084-78-5 | sc-207749 | 100 mg | $300.00 | ||
This bisphosphonate could indirectly stimulate EEIG1 expression as a response to its potent inhibition of bone resorption, which might trigger compensatory mechanisms in osteoclasts involving the upregulation of genes like EEIG1 to overcome the drug-induced blockade. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
Synthetic analogs of this lipid compound could induce EEIG1 expression by activating prostaglandin receptors involved in inflammatory responses and bone remodeling, which may include an increase in EEIG1 as a mediator in these processes. | ||||||